- Home
- DWTX vs WATT Comparison
DWTX vs WATT Comparison
Compare DWTX & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWTX
- WATT
- Stock Information
- Founded
- DWTX 2012
- WATT 2012
- Country
- DWTX United States
- WATT United States
- Employees
- DWTX N/A
- WATT N/A
- Industry
- DWTX
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- DWTX
- WATT Technology
- Exchange
- DWTX NYSE
- WATT Nasdaq
- Market Cap
- DWTX 9.2M
- WATT 9.3M
- IPO Year
- DWTX N/A
- WATT 2014
- Fundamental
- Price
- DWTX $4.79
- WATT $0.51
- Analyst Decision
- DWTX Strong Buy
- WATT
- Analyst Count
- DWTX 1
- WATT 0
- Target Price
- DWTX $10.00
- WATT N/A
- AVG Volume (30 Days)
- DWTX 27.2K
- WATT 1.6M
- Earning Date
- DWTX 08-14-2025
- WATT 08-07-2025
- Dividend Yield
- DWTX N/A
- WATT N/A
- EPS Growth
- DWTX N/A
- WATT N/A
- EPS
- DWTX N/A
- WATT N/A
- Revenue
- DWTX N/A
- WATT $1,047,000.00
- Revenue This Year
- DWTX N/A
- WATT $1,028.91
- Revenue Next Year
- DWTX N/A
- WATT N/A
- P/E Ratio
- DWTX N/A
- WATT N/A
- Revenue Growth
- DWTX N/A
- WATT 137.41
- 52 Week Low
- DWTX $1.62
- WATT $0.12
- 52 Week High
- DWTX $29.28
- WATT $2.70
- Technical
- Relative Strength Index (RSI)
- DWTX N/A
- WATT 75.23
- Support Level
- DWTX N/A
- WATT $0.38
- Resistance Level
- DWTX N/A
- WATT $0.44
- Average True Range (ATR)
- DWTX 0.00
- WATT 0.03
- MACD
- DWTX 0.00
- WATT 0.01
- Stochastic Oscillator
- DWTX 0.00
- WATT 88.73
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.